Anrotenib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anrotenib, covering 2020-01-18 to 2020-01-18. Get the full timeline:
Most recent: Clinical Trial Update: Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell Carcinoma [Phase 2]